Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2018, Article ID 2706751, 4 pages
https://doi.org/10.1155/2018/2706751
Case Report

In Vitro Fertilization Using Luteinizing Hormone-Releasing Hormone Injections Resulted in Healthy Triplets without Increased Attack Rates in a Hereditary Angioedema Case

Department of Internal Medicine, Division of Allergy and Clinical Immunology, Ege University Medical Faculty, İzmir, Turkey

Correspondence should be addressed to Ceyda Tunakan Dalgıç; moc.oohay@tadyec_rd

Received 20 October 2017; Revised 5 January 2018; Accepted 22 January 2018; Published 13 February 2018

Academic Editor: Jiri Litzman

Copyright © 2018 Ceyda Tunakan Dalgıç et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Agostoni, E. Aygören-Pürsün, K. E. Binkley et al., “Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond,” The Journal of Allergy and Clinical Immunology, vol. 114, no. 3, pp. S51–S131, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Caballero, H. Farkas, L. Bouillet et al., “International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency,” The Journal of Allergy and Clinical Immunology, vol. 129, no. 2, pp. 308–320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Bouillet, H. Longhurst, I. Boccon-Gibod et al., “Disease expression in women with hereditary angioedema,” American Journal of Obstetrics & Gynecology, vol. 199, no. 5, pp. 484–e4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Czaller, B. Visy, D. Csuka, G. Füst, F. Tóth, and H. Farkas, “The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: A long-term survey,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 152, no. 1, pp. 44–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Martinez-Saguer, E. Rusicke, E. Aygören-Pürsün, C. Heller, T. Klingebiel, and W. Kreuz, “Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate,” American Journal of Obstetrics & Gynecology, vol. 203, no. 2, pp. 131–e7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Caballero, J. Canabal, D. Rivero-Paparoni, and R. Cabañas, “Management of hereditary angioedema in pregnant women: A review,” International Journal of Women's Health, vol. 6, pp. 839–848, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Banerji and M. Riedl, “Managing the female patient with hereditary angioedema,” Women's Health Journal (WHJ), vol. 12, no. 3, pp. 351–361, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Bouillet and A. Gompel, “Hereditary angioedema in women: specific challenges,” Immunology and Allergy Clinics of North America, vol. 33, no. 4, pp. 505–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Kumar and A. Sharma, “Gonadotropin-releasing hormone analogs: Understanding advantages and limitations,” Journal of Human Reproductive Sciences, vol. 7, no. 3, p. 170, 2014. View at Publisher · View at Google Scholar
  10. R. Depalo, K. Jayakrishnan, G. Garruti et al., “GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET),” Reproductive Biology and Endocrinology, vol. 10, article 26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. B. L. Zuraw, P. J. Busse, M. White et al., “Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema,” The New England Journal of Medicine, vol. 363, no. 6, pp. 513–522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Bernstein, M. E. Manning, H. Li et al., “Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema,” Journal of Allergy and Clinical Immunology: In Practice, vol. 2, no. 1, pp. 77–84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Bouillet, “Hereditary angioedema in women,” Allergy, Asthma & Clinical Immunology, vol. 6, no. 1, p. 17, 2010. View at Publisher · View at Google Scholar
  14. T. González-Quevedo, J. I. Larco, C. Marcos et al., “Management of pregnancy and delivery in patients with hereditary angioedema due to C1 inhibitor deficiency,” Journal of Investigational Allergology and Clinical Immunology, vol. 26, no. 3, pp. 161–167, 2016. View at Publisher · View at Google Scholar · View at Scopus